SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,637,416 | +8773.0% | 138,644 | +7208.6% | 2.77% | +4600.0% |
| Q3 2020 | $266,396 | -97.7% | 1,897 | -97.4% | 0.06% | -96.3% |
| Q2 2020 | $11,501,349 | +18.8% | 71,731 | -4.4% | 1.58% | -7.7% |
| Q4 2019 | $9,678,000 | +284.8% | 75,000 | +353.1% | 1.71% | +142.8% |
| Q2 2019 | $2,515,380 | -74.7% | 16,554 | -80.2% | 0.70% | -75.8% |
| Q1 2019 | $9,961,185 | +125.4% | 83,574 | +106.4% | 2.91% | +21.4% |
| Q4 2018 | $4,419,110 | -35.2% | 40,494 | -4.0% | 2.39% | -20.0% |
| Q3 2018 | $6,814,753 | +28.9% | 42,194 | +5.5% | 2.99% | +23.7% |
| Q2 2018 | $5,287,200 | – | 40,000 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |